These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 28241076)
1. Characterisation of liver fat in the UK Biobank cohort. Wilman HR; Kelly M; Garratt S; Matthews PM; Milanesi M; Herlihy A; Gyngell M; Neubauer S; Bell JD; Banerjee R; Thomas EL PLoS One; 2017; 12(2):e0172921. PubMed ID: 28241076 [TBL] [Abstract][Full Text] [Related]
2. Assessment of a high-SNR chemical-shift-encoded MRI with complex reconstruction for proton density fat fraction (PDFF) estimation overall and in the low-fat range. Park CC; Hooker C; Hooker JC; Bass E; Haufe W; Schlein A; Covarrubias Y; Heba E; Bydder M; Wolfson T; Gamst A; Loomba R; Schwimmer J; Hernando D; Reeder SB; Middleton M; Sirlin CB; Hamilton G J Magn Reson Imaging; 2019 Jan; 49(1):229-238. PubMed ID: 29707848 [TBL] [Abstract][Full Text] [Related]
3. Inter-reader agreement of magnetic resonance imaging proton density fat fraction and its longitudinal change in a clinical trial of adults with nonalcoholic steatohepatitis. Hooker JC; Hamilton G; Park CC; Liao S; Wolfson T; Dehkordy SF; Hong CW; Mamidipalli A; Gamst A; Loomba R; Sirlin CB Abdom Radiol (NY); 2019 Feb; 44(2):482-492. PubMed ID: 30128694 [TBL] [Abstract][Full Text] [Related]
4. Bone marrow fat content is correlated with hepatic fat content in paediatric non-alcoholic fatty liver disease. Yu NY; Wolfson T; Middleton MS; Hamilton G; Gamst A; Angeles JE; Schwimmer JB; Sirlin CB Clin Radiol; 2017 May; 72(5):425.e9-425.e14. PubMed ID: 28063601 [TBL] [Abstract][Full Text] [Related]
5. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study. Brouha SS; Nguyen P; Bettencourt R; Sirlin CB; Loomba R Eur Radiol; 2018 Apr; 28(4):1345-1355. PubMed ID: 29058029 [TBL] [Abstract][Full Text] [Related]
6. Differences in multi-echo chemical shift encoded MRI proton density fat fraction estimation based on multifrequency fat peaks selection in non-alcoholic fatty liver disease patients. Martí-Aguado D; Alberich-Bayarri Á; Martín-Rodríguez JL; França M; García-Castro F; González-Cantero J; González-Cantero Á; Martí-Bonmatí L Clin Radiol; 2020 Nov; 75(11):880.e5-880.e12. PubMed ID: 32888653 [TBL] [Abstract][Full Text] [Related]
7. Cross-sectional correlation between hepatic R2* and proton density fat fraction (PDFF) in children with hepatic steatosis. Mamidipalli A; Hamilton G; Manning P; Hong CW; Park CC; Wolfson T; Hooker J; Heba E; Schlein A; Gamst A; Durelle J; Paiz M; Middleton MS; Schwimmer JB; Sirlin CB J Magn Reson Imaging; 2018 Feb; 47(2):418-424. PubMed ID: 28543915 [TBL] [Abstract][Full Text] [Related]
8. Association between Liver MRI Proton Density Fat Fraction and Liver Disease Risk. Xia T; Du M; Li H; Wang Y; Zha J; Wu T; Ju S Radiology; 2023 Oct; 309(1):e231007. PubMed ID: 37874242 [TBL] [Abstract][Full Text] [Related]
9. Reference range of liver corrected T1 values in a population at low risk for fatty liver disease-a UK Biobank sub-study, with an appendix of interesting cases. Mojtahed A; Kelly CJ; Herlihy AH; Kin S; Wilman HR; McKay A; Kelly M; Milanesi M; Neubauer S; Thomas EL; Bell JD; Banerjee R; Harisinghani M Abdom Radiol (NY); 2019 Jan; 44(1):72-84. PubMed ID: 30032383 [TBL] [Abstract][Full Text] [Related]
10. Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Ajmera V; Park CC; Caussy C; Singh S; Hernandez C; Bettencourt R; Hooker J; Sy E; Behling C; Xu R; Middleton MS; Valasek MA; Faulkner C; Rizo E; Richards L; Sirlin CB; Loomba R Gastroenterology; 2018 Aug; 155(2):307-310.e2. PubMed ID: 29660324 [TBL] [Abstract][Full Text] [Related]
11. MRI-determined liver proton density fat fraction, with MRS validation: Comparison of regions of interest sampling methods in patients with type 2 diabetes. Vu KN; Gilbert G; Chalut M; Chagnon M; Chartrand G; Tang A J Magn Reson Imaging; 2016 May; 43(5):1090-9. PubMed ID: 26536609 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of Fatty Liver Disease and Hepatic Iron Overload in a Northeastern German Population by Using Quantitative MR Imaging. Kühn JP; Meffert P; Heske C; Kromrey ML; Schmidt CO; Mensel B; Völzke H; Lerch MM; Hernando D; Mayerle J; Reeder SB Radiology; 2017 Sep; 284(3):706-716. PubMed ID: 28481195 [TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of low hepatic fat content in advanced chronic liver disease: MRI-PDFF insights. Nakamura A; Yoshimura T; Ichikawa T; Okuyama K Ann Hepatol; 2024; 29(4):101507. PubMed ID: 38723748 [TBL] [Abstract][Full Text] [Related]
14. Accuracy and precision of proton density fat fraction measurement across field strengths and scan intervals: A phantom and human study. Kim HJ; Cho HJ; Kim B; You MW; Lee JH; Huh J; Kim JK J Magn Reson Imaging; 2019 Jul; 50(1):305-314. PubMed ID: 30430684 [TBL] [Abstract][Full Text] [Related]
15. Free-breathing 3-D quantification of infant body composition and hepatic fat using a stack-of-radial magnetic resonance imaging technique. Armstrong T; Ly KV; Ghahremani S; Calkins KL; Wu HH Pediatr Radiol; 2019 Jun; 49(7):876-888. PubMed ID: 31001664 [TBL] [Abstract][Full Text] [Related]
16. Three-dimensional analysis of pancreatic fat by fat-water magnetic resonance imaging provides detailed characterization of pancreatic steatosis with improved reproducibility. Kato S; Iwasaki A; Kurita Y; Arimoto J; Yamamoto T; Hasegawa S; Sato T; Imajo K; Hosono K; Kobayashi N; Yoneda M; Higurashi T; Kubota K; Utsunomiya D; Nakajima A PLoS One; 2019; 14(12):e0224921. PubMed ID: 31790429 [TBL] [Abstract][Full Text] [Related]
17. Hepatic R2* is more strongly associated with proton density fat fraction than histologic liver iron scores in patients with nonalcoholic fatty liver disease. Bashir MR; Wolfson T; Gamst AC; Fowler KJ; Ohliger M; Shah SN; Alazraki A; Trout AT; Behling C; Allende DS; Loomba R; Sanyal A; Schwimmer J; Lavine JE; Shen W; Tonascia J; Van Natta ML; Mamidipalli A; Hooker J; Kowdley KV; Middleton MS; Sirlin CB; J Magn Reson Imaging; 2019 May; 49(5):1456-1466. PubMed ID: 30318834 [TBL] [Abstract][Full Text] [Related]
18. Validation of a motion-robust 2D sequential technique for quantification of hepatic proton density fat fraction during free breathing. Pooler BD; Hernando D; Ruby JA; Ishii H; Shimakawa A; Reeder SB J Magn Reson Imaging; 2018 Dec; 48(6):1578-1585. PubMed ID: 29665193 [TBL] [Abstract][Full Text] [Related]
19. Genome-wide Studies Reveal Genetic Risk Factors for Hepatic Fat Content. Li Y; van den Berg EH; Kurilshikov A; Zhernakova DV; Gacesa R; Hu S; Lopera-Maya EA; Zhernakova A; ; de Meijer VE; Sanna S; Dullaart RPF; Blokzijl H; Festen EAM; Fu J; Weersma RK Genomics Proteomics Bioinformatics; 2024 Jul; 22(2):. PubMed ID: 39142818 [TBL] [Abstract][Full Text] [Related]
20. Measurement of liver iron by magnetic resonance imaging in the UK Biobank population. McKay A; Wilman HR; Dennis A; Kelly M; Gyngell ML; Neubauer S; Bell JD; Banerjee R; Thomas EL PLoS One; 2018; 13(12):e0209340. PubMed ID: 30576354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]